Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

CUSIP: 603380205

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
45,675,986
Total 13F shares
23,063,409
Share change
+19,428,234
Total reported value
$90,576,655
Price per share
$4.02
Number of holders
29
Value change
+$76,545,252
Number of buys
19
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13D/G 13F
Company
20%
9,392,275
$35,502,800 +$30,394,980 22 Dec 2025
Vivo Opportunity Fund Holdings, L.P.
13D/G
10%
8,591,572
$32,476,142 $0 23 Dec 2025
Logos Global Management LP
13D/G
9.9%
4,435,444
$18,407,093 $0 23 Dec 2025
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
10%
4,539,854
$18,250,213 $0 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P.
13D/G
10%
4,330,315
$17,970,807 $0 31 Dec 2025
Adage Capital Management, L.P.
13D/G
6.4%
2,838,000
$11,777,700 $0 31 Dec 2025
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
3/4/5
10%+ Owner
class O/S missing
1,275,000
$4,794,000 27 Jun 2023
VANGUARD GROUP INC
13F
Company
0.55%
252,029
$534,302 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
116,500
$245,234 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
75,625
$160,357 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.16%
72,669
$152,968 30 Sep 2025
13F
Apella Capital, LLC
13F
Company
0.09%
39,314
$99,484 30 Sep 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.04%
17,416
$36,000 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.04%
16,519
$35,020 30 Sep 2025
13F
ADAR1 Capital Management, LLC
13F
Company
0.03%
12,406
$26,115 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.02%
11,008
$23,172 30 Sep 2025
13F
Rangeley Capital, LLC
13F
Company
0.02%
10,000
$21,050 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
2,430
$5,000 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,341
$2,823 30 Sep 2025
13F
CWM, LLC
13F
Company
0%
420
$1,000 30 Sep 2025
13F
Groupe la Francaise
13F
Individual
0%
337
$603 30 Sep 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
162
$341 30 Sep 2025
13F
Farther Finance Advisors, LLC
13F
Company
0%
100
$211 30 Sep 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
100
$211 30 Sep 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
62
$131 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
50
$106 30 Sep 2025
13F
Anchor Investment Management, LLC
13F
Company
0%
12
$25 30 Sep 2025
13F
UBS Group AG
13F
Company
0%
10
$21 30 Sep 2025
13F
BARCLAYS PLC
13F 3/4/5
Company · 10%+ Owner
0%
1
$2 30 Sep 2025
CITIGROUP INC
13F
Company
0%
1
$2 30 Sep 2025
13F
Remy Luthringer
3/4/5
CEO, Director
class O/S missing
2,250,000
22 Dec 2025
Boehringer AG
13D/G
3.4%
1,500,225
$0 23 Dec 2025
Geoff Race
3/4/5
President
class O/S missing
1,500,000
22 Dec 2025
Frederick W. Ahlholm
3/4/5
SVP, CFO and Secretary
class O/S missing
500,000
22 Dec 2025
David Kupfer
3/4/5
Director
class O/S missing
50,000
22 Dec 2025
Fouzia Laghrissi-Thode
3/4/5
Director
class O/S missing
50,000
22 Dec 2025
Hans Peter Hasler
3/4/5
Director
class O/S missing
50,000
22 Dec 2025
VAN HEEK G JAN
3/4/5
Director
class O/S missing
50,000
22 Dec 2025
Jeryl L. Hilleman
3/4/5
Director
class O/S missing
12,500
27 Sep 2023
William F. Doyle
3/4/5
Director
class O/S missing
2,500
10 Jun 2022

Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q4 2025

As of 31 Dec 2025, Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,063,409 shares. The largest 10 holders included FEDERATED HERMES, INC., Vivo Capital, LLC, Logos Global Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., FARALLON CAPITAL MANAGEMENT LLC, Ally Bridge Group (NY) LLC, Spruce Street Capital LP, ACUTA CAPITAL PARTNERS, LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
22
Q4 2025 holders
29
Holder diff
7
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .